相关实验视频

Updated: May 6, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

在巨细胞动脉炎中使用静脉注射甲基普雷迪尼索隆:基于人口的研究

Hampus Henningson¹, Björn Hammar², Aladdin J Mohammad^1,3

¹Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden.

Rheumatology (Oxford, England)

|August 27, 2024

概括

静脉注射甲基prednisolone (IVMP) 没有改善巨细胞动脉炎 (GCA) 患者的视力敏度或生存率. 然而,IVMP在GCA诊断后一年内增加患糖尿病的风险.

科学领域:

类风湿病学类风湿病学
内部医学内部医学
眼科医生眼科眼科

背景情况:

巨细胞动脉炎 (GCA) 是一种系统性血管炎,影响大动脉.
治疗策略旨在预防视力丧失和其他并发症.
静脉注射甲基prednisolone (IVMP) 与口服葡萄皮质类药物 (OGC) 在GCA管理中的作用是有争议的.

研究的目的:

为了比较IVMP治疗的GCA患者的临床特征,治疗结果和并发症发生率与OGC治疗.
评估IVMP对视敏度 (VA) 和生存时间的影响.
评估GCA诊断后发展新的并发症,特别是糖尿病的风险.

主要方法:

对419名在2004年至2019年期间被诊断为GCA的活检确认患者进行了回顾性研究.
临床和实验室数据的比较,IVMP和OGC组之间的累积葡萄糖皮质体剂量.
分析VA的变化,并发症的发生和GCA诊断后的死亡率.

主要成果:

IVMP组在呈现时显示出较低的炎症反应,但与OGC相比,VA没有统计学上显著的改善.
接受IVMP治疗的患者在GCA诊断后一年内出现新发糖尿病的风险显著增加 (OR2.59).
这种糖尿病风险增加在对累积OGC剂量进行调整后仍然存在,并且在两组之间没有观察到生存率的差异.

结论:

目前的证据不支持IVMP用于改善VA或GCA患者的存活率.
在GCA诊断的第一年内,IVMP治疗可能与患上糖尿病的风险增加有关.
需要进一步的研究来澄清IVMP在GCA管理中的特定好处和风险.

关键词:

这种疾病是共患的.巨细胞动脉炎的发生静脉内注射的甲基前尼索隆 (Methylprednisolone) 是一种结果结果结果结果.幸存率幸存率生存率视觉表现是一种视觉表现.

更多相关视频

Knee Arthrocentesis in Adults

Knee Arthrocentesis in Adults

Published on: February 25, 2022

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

相关概念视频

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...